Science and technology company Battelle disclosed on Monday that Dr Wayne A I Frederick, current president of Howard University and the Charles R Drew Professor of Surgery, has been elected to the Battelle board of directors.
Dr Frederick will initially serve in an advisory role and will become a full voting member on the company's board in 2022.
Following post-doctoral research and surgical oncology fellowships at the University of Texas MD Anderson Cancer Center, Dr Frederick began his academic career as associate director of the cancer center at the University of Connecticut. He was appointed the seventeenth president of Howard University in 2014 and has been responsible for advancing the university's commitment to student opportunity, academic innovation, public service, and fiscal stability. He previously served as provost and chief academic officer.
Currently, Dr Frederick serves on the board of directors for the Federal Reserve Bank of Richmond and Humana Inc.
Headquartered in Columbus, Ohio and founded in 1929, Battelle conducts research and development, designs and manufactures products, and delivers critical services for government and commercial customers. Battelle also supports science, technology, engineering and mathematics (STEM) education.
Rx to Go receives ACHC re-accreditation for pharmacy services
San Luis Obispo Family Dentist Publishes 'A Parent's Quick Guide to Family Dentistry'
BioDlink makes first international shipment of bevacizumab to Colombia
4basebio synthetic DNA used in Phase I/II mRNA therapy trial
Johnson & Johnson reports durable two-year remission data for TREMFYA in Crohn's disease
Jacabio reports pre-clinical data for JAB-23E73 pan-KRAS inhibitor at international conference
Orion secures exclusive commercial licence for Abzena cancer antibody
Boehringer Ingelheim's JASCAYD (nerandomilast) IPF treatment gains Chinese regulatory approval
ACM Biolabs reports ACM-CpG Phase 1 study findings in tumour treatment
Galera Therapeutics sells dismutase mimetics portfolio to Biossil in USD108.5m agreement
BD launches IVDR-certified self-collection solution to expand global access to HPV testing